NRIX
$24.42-2.12%
Nurix Therapeutics Inc.Stock · HealthcareRussell 2000 0.07%Nasdaq Composite 0.006%US Stock Market 0.003%Russell 3000 0.003%
Nurix Therapeutics Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
Nurix Therapeutics Inc. total returns by year (2021–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $18.97 | $24.42 | 0.0% | +28.7% | |
| 2025 | $18.84 | $18.97 | 0.0% | +0.7% | |
| 2024 | $10.32 | $18.84 | 0.0% | +82.6% | |
| 2023 | $10.98 | $10.32 | 0.0% | -6.0% | |
| 2022 | $28.95 | $10.98 | 0.0% | -62.1% | |
| 2021 | $32.88 | $28.95 | 0.0% | -12.0% |
- Annualized
- +3.8%
- 2021–2026
- Average year
- +0.6%
- 5 full years
- Best year
- +82.6%
- 2024
- Worst year
- -62.1%
- 2022
- Positive years
- 2/5
- 40% up
Annualized (CAGR)
+3.8%
2021–2026
Average year
+0.6%
5 full years
Best year
+82.6%
2024
Worst year
-62.1%
2022
Positive years
2/5
40% up
Total return by period#
Annual
-50%0%50%
2021-12%'21
2022-62%'22
2023-6.0%'23
2024+83%'24
2025+0.69%'25
2026+29%'26
Methodology#
Total returns, dividends reinvested, measured on NRIX. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Nurix Therapeutics Inc.'s average annual return?
- Since 2021, Nurix Therapeutics Inc. (NRIX) has returned about 3.8% a year (the compound annual growth rate) and an average calendar-year return of 0.6%.
- What were Nurix Therapeutics Inc.'s best and worst years?
- Over 2021–2026, the best year was 2024 (+82.6%) and the worst was 2022 (-62.1%).
- How often is Nurix Therapeutics Inc. up in a year?
- 2 of the 5 full years since 2021 were positive — about 40% of the time.
More on Nurix Therapeutics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100